Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Viemed Healthcare, Inc.

VMD

Valuace

26

Růst

45

Zdraví

72

Cena

$ 9.21

-0.21 (-2.79%)

Návštěvnost webu

Zprávy společnosti

Výsledovka

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total Revenues		270.3	270.3	224.3	183.0	138.8	117.1	131.3	80.3	65.3	46.9	31.4
Cost of Revenues		116.3	116.3	91.1	70.2	54.2	43.7	51.2	24.3	16.7	12.3	12.5
Gross Profit		154.0	154.0	133.2	112.8	84.7	73.4	80.1	56.0	48.6	34.6	18.9

Revenue		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues		76.2	71.9	63.1	59.1	60.7	58.0	55.0	50.6	52.1	49.4
Cost of Revenues		33.2	30.6	26.7	25.9	24.6	23.6	22.1	20.8	19.6	18.8
Gross Profit		43.0	41.3	36.4	33.3	36.1	34.4	32.9	29.8	32.6	30.6

Operating Income		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
R&D Expenses		0.0	0.0	0.0	2.8	2.7	2.1	1.1	0.8	0.0	0.0	0.0
Selling General & Admin Expenses		0.0	0.0	0.0	93.2	73.4	60.0	57.7	45.3	30.9	20.2	13.8
Depreciation & Amortization		28.6	28.6	25.4	21.9	16.3	12.2	7.3	6.9	3.8	2.5	1.4
Total Operating Expenses		132.1	132.1	115.3	98.5	76.1	61.4	55.7	46.8	31.5	20.6	14.1
Operating Income		21.8	21.8	17.9	14.3	8.3	11.6	26.8	8.7	17.0	8.8	0.4

Operating Income		TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6
Selling General & Admin Expenses		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	25.1
Depreciation & Amortization		7.6	7.5	6.9	6.6	6.4	6.4	6.3	6.3	5.9	6.0
Total Operating Expenses		35.1	35.7	31.9	29.4	29.7	28.7	29.3	27.6	26.8	26.1
Operating Income		7.8	5.6	4.5	3.8	6.5	5.6	3.6	2.2	5.8	4.2

Net Income		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Interest Income		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense		1.2	1.2	0.8	0.4	0.2	0.3	0.5	0.3	0.2	0.3	0.3
Other Expense		-0.1	-0.1	-1.7	0.1	0.7	0.9	-0.4	0.0	-6.5	-5.5	-4.3
IBT		21.8	21.8	16.2	14.4	9.0	12.5	26.4	8.8	10.3	8.2	0.1
Income Tax Expense		6.4	6.4	4.8	4.1	2.8	3.4	-5.2	0.3	0.2	0.0	-1.1
Net Income		14.9	14.9	11.3	10.2	6.2	9.1	31.5	8.5	10.2	8.2	1.2

Net Income		TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2
Interest Expense		0.4	0.5	0.1	0.2	0.1	0.2	0.3	0.2	0.3	0.2
Other Expense		0.2	-0.5	0.5	-0.2	-0.1	-0.1	-1.4	-0.1	-0.2	0.0
IBT		8.0	5.1	5.0	3.7	6.3	5.5	2.2	2.1	5.2	4.2
Income Tax Expense		2.2	1.5	1.7	1.0	1.9	1.6	0.8	0.5	1.6	1.3
Net Income		5.6	3.5	3.2	2.6	4.3	3.9	1.5	1.6	3.5	2.9

Per Share Data		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
EPS		$0.00	$0.00	$0.00	$0.27	$0.16	$0.23	$0.81	$0.23	$0.27	$0.22	$0.03
EPS Diluted		$0.00	$0.00	$0.00	$0.25	$0.16	$0.22	$0.78	$0.21	$0.26	$0.22	$0.03
Shares Outstanding		38.0	38.9	38.8	38.4	38.7	39.5	38.7	37.7	37.9	37.9	37.9
Diluted Shares Outstanding		40.2	40.8	40.8	40.4	39.8	40.7	40.5	39.7	39.7	38.0	37.9

Per Share Data		TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.09	$0.08
EPS Diluted		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.09	$0.07
Shares Outstanding		38.0	38.6	39.5	39.4	39.0	38.9	38.8	38.7	38.5	38.4
Diluted Shares Outstanding		40.2	40.5	41.1	41.6	41.5	40.8	40.6	40.6	40.4	40.4

Current Assets		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Cash And Equivalents		8.8	17.5	12.8	16.9	28.4	31.0	13.4	10.4	5.1	4.3
Short Term Investments		0.0	0.0	0.0	-2.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Cash & ST Investments		8.8	17.5	12.8	16.9	28.4	31.0	13.4	10.4	5.1	4.3
Accounts Receivable		27.5	24.9	18.5	15.4	14.7	12.4	11.5	8.8	9.8	4.8
Inventory		4.4	4.3	4.6	3.6	2.5	2.3	1.4	2.9	1.6	1.6
Other Current Assets		4.2	6.1	2.4	3.8	1.7	1.5	1.6	0.8	0.5	0.4
Total Current Assets		45.0	52.9	38.4	39.7	47.3	47.2	27.8	23.0	17.0	11.2

Current Assets		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents		11.1	20.0	10.2	17.5	11.3	8.8	7.3	12.8	10.1	10.2
Short Term Investments		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-2.2	0.0
Total Cash & ST Investments		11.1	20.0	10.2	17.5	11.3	8.8	7.3	12.8	10.1	10.2
Accounts Receivable		29.3	26.5	26.8	24.9	27.1	27.5	24.5	18.5	17.9	18.9
Inventory		5.3	4.3	4.5	4.3	4.3	4.4	4.3	4.6	4.7	4.5
Other Current Assets		4.3	4.4	7.7	6.1	5.0	4.2	2.5	2.4	3.2	2.3
Total Current Assets		50.0	55.3	49.1	52.9	47.7	45.0	38.6	38.2	35.9	35.9

Long-Term Assets		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Property, Plant & Equipment		77.7	79.2	76.9	68.4	62.8	55.1	54.8	30.6	20.7	13.5
Goodwill		33.0	33.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets		0.9	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments		2.8	2.8	3.9	4.2	2.2	0.7	0.0	0.0	0.0	0.0
Other Long-Term Assets		0.0	0.0	0.9	1.6	0.9	0.9	0.0	0.0	0.0	0.0
Total Long-Term Assets		119.0	124.2	116.5	77.3	70.7	65.4	54.8	30.6	20.7	13.5
Total Assets		163.9	177.1	154.9	117.0	118.0	112.6	82.6	53.5	37.7	24.7

Long-Term Assets		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment		84.1	82.4	84.0	79.2	77.2	77.7	76.5	76.5	74.4	73.9
Goodwill		58.5	33.0	33.0	33.0	33.0	33.0	29.8	29.6	29.7	29.8
Intangible Assets		1.3	0.8	0.8	0.8	0.9	0.9	0.5	0.6	0.7	0.7
Long-Term Investments		2.8	2.8	2.8	2.8	2.7	2.8	4.0	3.9	3.9	4.1
Other Long-Term Assets		0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.9	0.9
Total Long-Term Assets		152.4	129.3	129.0	124.2	121.8	119.0	116.3	115.9	113.5	113.2
Total Assets		202.4	184.6	178.1	177.1	169.5	163.9	154.9	154.1	149.4	149.1

Current Liabilities		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Accounts Payable		6.3	5.3	7.4	2.7	3.2	2.1	4.7	5.9	3.4	1.9
Short-Term Debt		1.6	1.3	2.0	0.5	1.9	4.6	8.8	3.0	4.4	3.9
Other Current Liabilities		16.8	20.2	14.3	11.1	8.9	12.9	9.1	7.9	0.2	0.5
Current Liabilities		31.5	37.3	32.1	18.9	17.8	23.0	25.9	17.0	13.1	9.2

Current Liabilities		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable		8.7	12.6	12.6	9.3	10.1	10.2	2.6	7.4	9.3	8.9
Short-Term Debt		2.7	1.7	1.3	1.3	1.6	1.6	1.5	2.0	3.0	3.9
Other Current Liabilities		25.0	14.3	12.9	16.1	15.8	12.9	17.2	14.4	12.8	12.8
Current Liabilities		44.2	37.3	35.5	37.3	36.4	31.5	30.1	32.0	31.6	31.6

Long-Term Liabilities		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Long-Term Debt		8.7	5.6	8.3	0.2	4.6	6.6	10.7	0.4	0.8	2.6
Capital Leases		2.1	2.9	3.3	0.7	0.7	3.5	10.1	3.4	5.2	6.0
Def. Tax Liability		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities		42.8	43.8	41.0	19.9	23.1	30.9	38.9	18.5	13.9	11.8

Long-Term Liabilities		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt		22.0	5.2	5.4	5.6	5.6	10.8	8.0	8.3	8.5	12.4
Capital Leases		0.0	2.6	2.8	2.9	2.8	3.0	3.0	2.3	1.0	1.1
Def. Tax Liability		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities		66.9	43.0	41.3	43.8	42.7	42.8	38.6	40.8	40.6	44.6

Total Common Equity		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Common Stock		21.9	23.4	18.7	15.1	14.0	9.2	3.4	0.1	0.1	0.1
Retained Earnings		81.6	89.7	79.5	69.8	73.3	65.6	34.1	29.6	21.0	12.8
Comprehensive Income		0.0	0.0	0.0	-0.3	-0.3	-0.5	-0.2	-8.8	-5.7	-3.5
Total Common Equity		119.4	131.4	113.9	97.1	94.8	81.7	43.7	35.0	23.7	12.9

Total Common Equity		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock		16.9	27.8	28.2	23.4	22.7	21.9	21.8	18.6	18.6	17.9
Retained Earnings		97.3	93.8	90.7	89.7	85.4	81.6	80.1	79.1	76.0	73.2
Comprehensive Income		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Common Equity		133.6	139.7	134.8	131.4	125.0	119.4	116.3	113.3	108.8	104.5

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total Debt		12.5	6.9	10.3	0.7	6.5	11.1	19.5	3.4	5.2	6.5
Book Value		121.2	133.3	113.9	97.1	94.8	81.7	43.7	35.0	23.7	12.9

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		1.9	1.9	2.0	1.9	1.8	1.8	0.0	0.0	0.0	0.0
Book Value		133.6	139.7	134.8	131.4	125.0	119.4	116.3	113.3	108.8	104.5

Cash Flow From Operating Activities		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Income		9.6	14.9	11.4	10.2	6.2	9.1	31.5	8.5	10.2	8.2	1.2
Depreciation & Amortization		24.7	28.6	25.4	21.9	15.6	11.3	9.6	6.4	3.8	2.5	1.4
Stock-Based Compensation		6.0	9.1	6.3	5.8	5.2	5.2	4.9	3.9	2.7	0.8	0.0
Change Working Capital		-2.3	-2.3	0.4	7.8	-10.1	-13.6	-10.2	-9.5	-0.7	-4.9	-0.6
Change In Accounts Receivable		-8.8	1.2	-6.1	-1.1	-12.6	-7.3	-10.0	-12.5	-5.3	-10.1	-1.1
Change In Accounts Payable		0.7	0.5	0.4	-0.9	-0.3	0.1	0.2	0.8	2.5	0.9	1.4
Change In Inventories		0.3	0.1	0.6	-0.5	0.3	-0.2	-2.3	-0.3	-1.3	0.0	-0.1
Other Non-cash Items		17.6	-1.6	-0.5	0.9	9.1	6.6	8.1	9.8	6.5	5.3	4.3
Cash from Operations		39.3	0.0	0.0	45.2	27.7	22.5	35.1	19.1	22.4	12.0	6.4

Cash Flow From Operating Activities		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income		5.7	3.6	3.2	2.7	4.4	3.9	1.5	1.6	3.6	2.9
Depreciation & Amortization		7.6	7.5	6.9	6.6	6.4	6.4	6.3	6.3	6.1	6.0
Stock-Based Compensation		2.3	2.2	2.3	2.3	1.5	1.7	1.6	1.4	1.5	1.5
Change Working Capital		2.0	-0.2	2.3	-6.4	4.1	8.2	0.1	-8.3	2.8	3.1
Change In Accounts Receivable		1.8	1.0	0.2	-1.9	2.1	0.0	-2.2	-6.0	-0.5	0.0
Change In Accounts Payable		-0.3	-0.8	0.4	1.2	-0.4	-1.1	0.5	0.6	-0.6	0.2
Change In Inventories		0.2	-0.2	0.2	-0.2	0.0	0.1	0.2	0.3	0.0	-0.2
Other Non-cash Items		0.5	0.5	-0.5	-2.3	-1.1	-4.0	0.7	0.1	0.8	0.4
Cash from Operations		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	13.8

Cash Flow From Investing Activities		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Capital Expenditure		-30.8	-40.0	-37.8	-26.1	-22.9	-19.7	-13.0	-13.4	-6.1	-4.0	-1.7
Acquisitions		-3.0	-26.3	-3.0	-28.6	-0.1	-0.6	-0.6	0.0	0.0	0.0	0.0
Investments		0.0	0.0	0.0	0.0	-2.0	0.0	0.0	0.0	0.0	0.0	0.0
Sales of Investment		0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Investing Activities		1.0	0.0	0.0	2.6	1.1	0.6	5.3	0.6	0.8	0.4	0.7
Cash from Investing		-33.4	0.0	0.0	-52.1	-24.0	-19.7	-8.4	-12.8	-5.3	-3.6	-0.9

Cash Flow From Investing Activities		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure		-8.7	-7.6	-8.1	-15.5	-11.8	-11.0	-8.9	-6.0	-8.4	-7.4
Acquisitions		6.4	-26.3	6.4	0.0	-1.0	-1.4	0.0	0.0	0.1	-1.5
Investments		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Sales of Investment		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Investing Activities		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4
Cash from Investing		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-8.4	-8.5

Cash Flow From Financing Activities		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Debt Repaid		-11.8	0.0	0.0	2.1	-5.8	-4.0	-10.9	-12.0	-10.2	-7.7	-4.3
Debt Issued		8.0	6.9	-3.5	11.7	0.0	-0.6	2.6	28.1	8.4	6.4	10.8
Issuance of Common Stock		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock		-1.0	-13.2	-1.1	-0.6	-9.7	-1.4	0.0	-1.5	-1.6	0.0	0.0
Dividends Paid		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities		-1.3	0.0	0.0	1.3	0.3	0.1	1.9	10.2	0.0	0.0	0.0
Cash from Financing		-7.3	0.0	0.0	2.8	-15.3	-5.3	-9.1	-3.3	-11.8	-7.7	-4.3

Cash Flow From Financing Activities		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.1	-5.4
Debt Issued		24.7	17.8	0.1	-0.1	-0.4	-5.2	2.9	-0.7	2.5	-0.1
Issuance of Common Stock		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock		-3.2	-11.7	-1.7	-1.6	0.0	-0.1	0.0	-1.0	0.0	-0.1
Dividends Paid		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Cash from Financing		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.0	-5.4

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Change in Cash		-1.4	-4.0	4.7	-4.1	-11.5	-2.6	17.6	2.9	5.3	0.8	1.2
Closing Cash Balance		8.8	13.5	17.5	12.8	16.9	28.4	31.0	13.4	10.4	5.1	4.3

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		2.4	-8.9	9.9	-7.4	6.2	2.5	1.5	-5.5	2.7	-0.1
Closing Cash Balance		13.5	11.1	20.0	10.2	17.5	11.3	8.8	7.3	12.8	10.1

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Free Cash Flow		8.5	11.9	1.3	19.1	4.9	2.8	22.1	5.7	16.3	8.0	4.7
Real Free Cash Flow		2.5	2.8	-5.0	13.3	-0.4	-2.4	17.2	1.8	13.6	7.2	4.7

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		9.7	10.7	4.1	-12.6	3.2	1.7	1.2	-4.8	5.7	6.4
Real Free Cash Flow		7.4	8.6	1.8	-14.9	1.6	0.0	-0.4	-6.3	4.2	5.0

Akciový screener

Kalendář zisků

Super investoři

Porovnání akcií